<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00932542</url>
  </required_header>
  <id_info>
    <org_study_id>CRT054</org_study_id>
    <nct_id>NCT00932542</nct_id>
  </id_info>
  <brief_title>Eutectic Mixture for Hemorrhoidectomy Postoperative</brief_title>
  <acronym>CRT054</acronym>
  <official_title>&quot;Topic Effects of Eutectic Mixture Use in Local Anesthetics on Hemorrhoidectomy Postoperative (Prospective Study, Randomized, Triple Blind, Placebo-controlled)&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Cristália Produtos Químicos Farmacêuticos Ltda.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the efficacy and safety of the topic use of an eutectic mixture of local anesthetics
      for postoperative pain control of patients submitted to hemorrhoidectomy. Patients will be
      operated and discharged at the same day in a day hospital clinic. During the fourteen days
      recovery period, they will apply the study medication to the anal region 4 times daily. The
      Visual Analog Pain Scale (VAS) will be answered twice daily. Patients will also take 100 mg
      oral nimesulide twice daily and 50 mg tramadol on demand up to 4 times daily. The tramadol
      demand will be tabulated. A rescue medication for analgesia will be provided (sodium
      diclofenac IM).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction of pain evaluated by the analgesics demand.</measure>
    <time_frame>Follow-up termination (1 month)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain reduction by VAS</measure>
    <time_frame>Follow-up termination (1 month)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerability by the adverse events incidence</measure>
    <time_frame>Follow-up termination (1 month)</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Hemorrhoidectomy</condition>
  <arm_group>
    <arm_group_label>Eutectic mixture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Medicaina</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eutectic mixture</intervention_name>
    <description>The eutectic mixture of lidocaine + prilocaine + bupivacaine.</description>
    <arm_group_label>Eutectic mixture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine 2,5%; prilocaine 2,5%</intervention_name>
    <description>lidocaine 2,5%; prilocaine 2,5%</description>
    <arm_group_label>Medicaina</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria: male and female patients, older than 18, having internal hemorrhoid
        disease grade III or IV with indication of elective surgery, anesthetic risk ASA 1 or 2;
        able to read and write.

        Exclusion criteria: allergy or hypersensitivity to the mixture components, perianal
        fistulas, fissures, ulcers, infectious and inflammatory processes or tumors to the anal
        region, chronic diarrhea, megacolon or colonic anatomical deformities, hemorrhoidal
        thrombosis, gangrene or any condition that changes the indication from elective to urgent,
        previous surgery to anal-rectal region, history or clinical signs of diabetes mellitis type
        I or II, pregnancy, intense anxiety or important emotional disorder, participation in any
        clinical trial within the 3 months preceding the inclusion, investigator´s opinion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clínica Reis Neto</name>
      <address>
        <city>Campinas</city>
        <state>São Paulo</state>
        <zip>13010-112</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2009</study_first_submitted>
  <study_first_submitted_qc>July 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2009</study_first_posted>
  <last_update_submitted>October 8, 2012</last_update_submitted>
  <last_update_submitted_qc>October 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Joaquim Simoes Neto</investigator_full_name>
    <investigator_title>Master Degree</investigator_title>
  </responsible_party>
  <keyword>Hemorrhoidectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

